PL3728567T3 - Metoda oceny synukleinopatii - Google Patents
Metoda oceny synukleinopatiiInfo
- Publication number
- PL3728567T3 PL3728567T3 PL18893211.5T PL18893211T PL3728567T3 PL 3728567 T3 PL3728567 T3 PL 3728567T3 PL 18893211 T PL18893211 T PL 18893211T PL 3728567 T3 PL3728567 T3 PL 3728567T3
- Authority
- PL
- Poland
- Prior art keywords
- synucleinopathy
- assessing
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Databases & Information Systems (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762607345P | 2017-12-19 | 2017-12-19 | |
| US201862742839P | 2018-10-08 | 2018-10-08 | |
| US201862769255P | 2018-11-19 | 2018-11-19 | |
| PCT/US2018/066612 WO2019126395A1 (en) | 2017-12-19 | 2018-12-19 | Methods for developing pharmaceuticals for treating neurodegenerative conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3728567T3 true PL3728567T3 (pl) | 2023-11-13 |
Family
ID=66993862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18893211.5T PL3728567T3 (pl) | 2017-12-19 | 2018-12-19 | Metoda oceny synukleinopatii |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200400687A1 (pl) |
| EP (2) | EP4273882A3 (pl) |
| JP (2) | JP7495878B2 (pl) |
| AU (1) | AU2018392605B2 (pl) |
| CA (1) | CA3087978A1 (pl) |
| ES (1) | ES2955992T3 (pl) |
| PL (1) | PL3728567T3 (pl) |
| WO (1) | WO2019126395A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220214360A1 (en) * | 2019-04-30 | 2022-07-07 | Chase Therapeutics Corporation | Alpha-synuclein assays |
| US20220351864A1 (en) * | 2019-09-30 | 2022-11-03 | Hoffmann-La Roche Inc. | Means and methods for assessing huntington's disease (hd) |
| US20230349906A1 (en) | 2019-12-31 | 2023-11-02 | Chase Therapeutics Corporation | Kinases as biomarkers for neurodegenerative conditions |
| CA3203308A1 (en) * | 2020-11-30 | 2022-06-02 | Enigma Biointelligence, Inc. | Non-invasive assessment of alzheimer's disease |
| EP4356143A4 (en) * | 2021-06-15 | 2025-04-09 | Chase Therapeutics Corporation | DIAGNOSTIC INDICES FOR NEURODEGENERATIVE DISEASES |
| CN115006427A (zh) * | 2022-05-31 | 2022-09-06 | 尧舜泽生物医药(南京)有限公司 | 骨髓间充质干细胞外泌体在治疗帕金森病中的应用 |
| TWI872376B (zh) * | 2022-10-05 | 2025-02-11 | 國防醫學院 | 紅血球外泌體粒子濃度於帕金森氏症之輔助診斷用途及其檢測方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7085788B2 (en) | 2003-12-03 | 2006-08-01 | Hitachi, Ltd. | Remote copy system configured to receive both a write request including a write time and a write request not including a write time. |
| AR052051A1 (es) * | 2004-12-15 | 2007-02-28 | Neuralab Ltd | Anticuerpos ab humanizados usados en mejorar la cognicion |
| US20070099239A1 (en) * | 2005-06-24 | 2007-05-03 | Raymond Tabibiazar | Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease |
| WO2008140639A2 (en) | 2007-02-08 | 2008-11-20 | Oligomerix, Inc. | Biomarkers and assays for alzheimer's disease |
| EP3470079A1 (en) | 2008-04-29 | 2019-04-17 | BioArctic AB | Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders |
| US20130178383A1 (en) * | 2008-11-12 | 2013-07-11 | David Spetzler | Vesicle isolation methods |
| RU2555526C2 (ru) | 2010-02-26 | 2015-07-10 | Байоарктик Ньюросайенс Аб | Антитела, связывающиеся с протофибриллами, и их применение в методах терапии и диагностики болезни паркинсона, деменции, ассоциированной с образованием диффузных телец леви, и других альфа-синуклеинопатий |
| JP6159662B2 (ja) * | 2011-03-01 | 2017-07-05 | イエール ユニバーシティ | 胃腸膵神経内分泌新生物（ｇｅｐ−ｎｅｎ）の予測方法 |
| DE102011057021A1 (de) * | 2011-12-23 | 2013-06-27 | Forschungszentrum Jülich GmbH | Verfahren zur selektiven Quantifizierung von A-Beta-Aggregaten |
| CA2867338A1 (en) | 2012-03-13 | 2013-09-19 | Janssen Alzheimer Immunotherapy | Oligomeric a.beta. in the diagnosis, prognosis, and monitoring of alzheimer's disease |
| US20140241987A1 (en) | 2013-02-28 | 2014-08-28 | United Arab Emirates University | Alpha-synuclein antibodies and uses thereof |
| US9261514B2 (en) * | 2013-07-15 | 2016-02-16 | New York University | Conformational-switching fluorescent protein probe for detection of alpha synuclein oligomers |
| JP6711754B2 (ja) * | 2013-10-24 | 2020-06-17 | ナノソミックス・インコーポレイテッドＮａｎｏＳｏｍｉＸ， Ｉｎｃ． | アルツハイマー病および他の神経変性障害のためのバイオマーカーおよび診断方法 |
| WO2015068075A2 (en) | 2013-10-24 | 2015-05-14 | Institut National De La Sante Et De La Recherche Medicale | Detection of tau |
| DK3110977T3 (en) | 2014-02-28 | 2018-07-23 | Exosome Sciences Inc | BRAIN SPECIFIC EXOSOME-BASED DIAGNOSTIC AND EXTRACORPORAL THERAPIES |
| JP6531171B2 (ja) * | 2014-06-27 | 2019-06-12 | エックスワイ エバーグリーン テクノロジー カンパニー | Ｃｎｓ由来エクソソームを富化するための方法 |
| GB201515223D0 (en) | 2015-08-27 | 2015-10-14 | Georg August Uni Gottingen Stiftung Offentlichen Rechts Universitatsmedizin | Method of differential diagnosis of dementia with Lewy bodies and Parkinson's disease |
| KR101807285B1 (ko) * | 2016-01-05 | 2017-12-08 | 한국과학기술연구원 | 비정상적인 응집 단백질의 올리고머 분석을 통한 질병 진단 방법 |
| KR101871895B1 (ko) * | 2016-04-20 | 2018-06-28 | 한국과학기술연구원 | 응집 단백질의 고감도 광 산화 증폭 면역 분석을 통한 체액기반의 퇴행성 신경질환 진단 방법 |
| WO2017210003A1 (en) * | 2016-05-31 | 2017-12-07 | Goetzl Edward J | Diagnostic method and drug efficacy test method for dementias utilizing astrocyte-derived exosomes |
-
2018
- 2018-12-19 JP JP2020535118A patent/JP7495878B2/ja active Active
- 2018-12-19 CA CA3087978A patent/CA3087978A1/en active Pending
- 2018-12-19 WO PCT/US2018/066612 patent/WO2019126395A1/en not_active Ceased
- 2018-12-19 US US16/946,345 patent/US20200400687A1/en not_active Abandoned
- 2018-12-19 EP EP23183398.9A patent/EP4273882A3/en not_active Withdrawn
- 2018-12-19 AU AU2018392605A patent/AU2018392605B2/en active Active
- 2018-12-19 EP EP18893211.5A patent/EP3728567B1/en active Active
- 2018-12-19 PL PL18893211.5T patent/PL3728567T3/pl unknown
- 2018-12-19 ES ES18893211T patent/ES2955992T3/es active Active
-
2024
- 2024-05-24 JP JP2024084514A patent/JP2024112950A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018392605B2 (en) | 2025-06-12 |
| EP4273882A2 (en) | 2023-11-08 |
| EP3728567B1 (en) | 2023-07-05 |
| JP2024112950A (ja) | 2024-08-21 |
| JP7495878B2 (ja) | 2024-06-05 |
| EP3728567A1 (en) | 2020-10-28 |
| EP3728567A4 (en) | 2021-09-22 |
| ES2955992T3 (es) | 2023-12-11 |
| WO2019126395A1 (en) | 2019-06-27 |
| JP2021508370A (ja) | 2021-03-04 |
| AU2018392605A1 (en) | 2020-07-30 |
| US20200400687A1 (en) | 2020-12-24 |
| EP4273882A3 (en) | 2024-01-03 |
| CA3087978A1 (en) | 2019-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3728567T3 (pl) | Metoda oceny synukleinopatii | |
| SG10201605758UA (en) | A Method For Preparing Transition Metal Phosphide | |
| GB201418219D0 (en) | A data block based backup method | |
| GB2543514B (en) | A Method for Preserving a Mark on a Metallic Workpiece | |
| GB201805954D0 (en) | A method | |
| GB201702825D0 (en) | A method for determining well depth | |
| GB2543334B (en) | A method for providing an alert | |
| SG10201606880RA (en) | Method for making a transaction | |
| GB201502290D0 (en) | A method for emmisions regulation | |
| SG11201708379RA (en) | A method for pile-driving | |
| EP3316065C0 (en) | METHOD FOR DETERMINING A PATH | |
| GB201814369D0 (en) | Method for determining a polymersequence | |
| GB2566249B (en) | A Method for Cleaning Casing | |
| PL3478485T3 (pl) | Sposób wytwarzania opony | |
| SG11201610359QA (en) | Method for determining a protein-protein interaction | |
| GB201406916D0 (en) | Method for checking a vehicle | |
| PL3136822T3 (pl) | Sposób określania temperatury | |
| GB201813722D0 (en) | A method | |
| GB201813730D0 (en) | A method | |
| GB201809530D0 (en) | A method | |
| GB2559745B (en) | A forming method | |
| GB201702792D0 (en) | A new biomarker for preeclampsia | |
| SG10201500384VA (en) | A verification method | |
| GB201808039D0 (en) | A method | |
| EP3658023C0 (en) | PROCESS FOR ASSESSING BALANCE |